In blood cancers such as chronic lymphocytic leukaemia, B cells of the immune system multiply uncontrollably.
Vous n'êtes pas connecté
In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of therapy involves labeling the CD20 protein on the surface of the B cells with customised antibodies. This triggers a chain of immunological reactions and ultimately leads to the destruction of the cancer cells. Such immunotherapeutic antibodies [...]
In blood cancers such as chronic lymphocytic leukaemia, B cells of the immune system multiply uncontrollably.
Since its discovery in the 1990s, “programmed cell death protein 1,” or PD-1, has been regarded as a leading target in cancer treatments. A...
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?
Immunotherapy is a modern approach to cancer treatment that uses a patient’s immune system to help fight tumours. It has made an incredible impact...
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?...
A group of immune proteins known as the inflammasome can prevent blood stem cells from becoming malignant by removing specific receptors from their...
Immune complexes, like the inflammasome, help protect stem cells from cancer by removing surface receptors and suppressing cancer gene activity.
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting...
Researchers at Oregon Health & Science University have uncovered how specialized cells surrounding small blood vessels, known as perivascular cells,...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to innovations in manufacturing — could make future cellular...